General Archive
-
News releasesApplying artificial intelligence in the search for new drugs
London, 11 April 2017 – BenevolentAI, a British artificial intelligence company, today announced that it has partnered with MRC Technology…
-
News releases
Dementia Consortium funds Manchester based team targeting immune system in search for new dementia treatments
The Dementia Consortium, a public-private partnership initiative bridging the gap between academic research and the pharmaceutical industry, is supporting a…
-
News releases
MRC Technology licenses antibody to Newsummit Biopharma for development of Hepatitis C virus infection therapeutic
MRC Technology has licensed an antibody to Newsummit Biopharma for development of a novel therapeutic for treatment of Hepatitis C…
-
News releases
MRC Technology joins project UTILE to enable medical breakthroughs from European funded research
MRC Technology is committed to ensuring that promising medical research is protected and progressed to benefit patients. We are therefore…
-
News releases
MRC Technology appoints Steve Visscher as new trustee
MRC Technology has appointed Steve Visscher CBE to its board of trustees.
-
News releases
MRC Technology, Cancer Research UK and Cancer Research Technology collaborate to focus on cancer immunotherapies
Cancer Research UK, Cancer Research Technology and MRC Technology are joining forces to identify and validate novel drug discovery targets…
-
News releases
MRC Technology invests £7 million to expand its diagnostics research capability in Scotland
MRC Technology, an independent medical research charity, has announced the relocation of its Centre for Diagnostics Development (CDD) to Nine,…
-
ArticlesPutting patient wellbeing and collaboration at the heart of what we do
Which treatment or diagnostic would make a patient’s life better? This is the starting point of what MRC Technology does.…
-
ArticlesRethinking drug research, before it’s too late
As we face the prospect of living in a ‘post-antibiotic’ era, there is renewed urgency to rethink the way we…
-
News releases
MRC Technology, UCB and the University of Leicester combine research excellence and expertise to evolve drug discovery
New research consortium aims to identify opportunities for drug discovery through the innovative use of antibodies in structure-based drug discovery…
-
News releases
New collaboration to explore novel treatments for respiratory diseases
A charity-industry collaboration has launched an initiative to find new epigenetic drug treatments to improve the lives of millions of…
-
News releases
MRC Technology monetises royalties on cancer drug Keytruda® (pembrolizumab) to expand medical research activities, with a fund managed by DRI Capital
MRC Technology has monetised a portion of its royalty interest in a leading cancer drug, pembrolizumab (marketed by Merck &…